Company Overview
About Aveo Oncology
Aveo Oncology is a biopharmaceutical company based in the United States. The company is focused on developing novel cancer treatments, including its lead product, tivozanib, which has received FDA approval for the treatment of metastatic renal cell carcinoma. Aveo Oncology's pipeline also includes other investigational therapies targeting various cancer types.
Frequently Asked Questions about Aveo Oncology
Technologies Used
Social Profiles
Key Decision Makers
Sarah R. Associate Director Clinical Operations